Procera: "16 Tier1 Trials; 15% growth in 2014"

Several quotes from Procera's Q4 earning call, by James Brear [pictured], President and CEO, and Charles Constanti, CFO:

We expect revenue growth of 15% in 2014 (see "DPI Market Grew by 10% in 2013 ($278M Revenues for Allot, Procera and Sandvine" - here) 

There are a number of dynamics we saw in the quarter that impacted our Q4 results. The shortfall relates to lower-than-expected orders